Investors who share their expertise
A diverse investor group that reflects strong support for a transformative approach to pathology.
20 experts with significant success in medical devices, education, technology-driven entrepreneurship, hardware and software development capitalized the company in 2021. The seed round was oversubscribed, and follows $3.4M in NIH sponsored grants.
$ 0 MM
$ 0 MM
in seed funds
$ 0 K
Meet The Team
Select Investors & Advisors
Applikate is backed and supported by investors and advisors carrying a wealth of professional experience and expertise. Not all investors featured here.